Hasil Pencarian  ::  Simpan CSV :: Kembali

"One of a series on current health issues which advises on the importance of nutrition in building up energy and fitness through eating the right nutrients and taking the best supplements. The book explains the symptoms and causes of eczema and dry skin, and natural and traditional remedies."

"The American consumer is bombarded with commercials and ads promoting the latest products "guaranteed" to produce a sleeker, younger appearance and new procedures that promise to end wrinkles and other unsightly skin problems. But how can you determine which are actually good and worthwhile, which are truly worthless and downright bad? Nelson Lee Novick, M.D., a nationally recognized dermatologist, provides answers to these and a great many other questions in his medically based, straightforward, practical guide to achieving healthier, younger-looking skin safely."

"The American consumer is bombarded with commercials and ads promoting the latest products "guaranteed" to produce a sleeker, younger appearance and new procedures that promise to end wrinkles and other unsightly skin problems. But how can you determine which are actually good and worthwhile, which are truly worthless and downright bad? Nelson Lee Novick, M.D., a nationally recognized dermatologist, provides answers to these and a great many other questions in his medically based, straightforward, practical guide to achieving healthier, younger-looking skin safely."

"Latar belakang: Baumann Skin Type Indicator (BSTI) merupakan instrumen yang dikembangkan pada tahun 2006 untuk menentukan tipe kulit berdasarkan empat parameter dikotom, yaitu: kering atau berminyak; sensitif atau resisten; berpigmen atau tidak berpigmen; dan kencang atau keriput. Kuesioner ini telah dimodifikasi pada tahun 2022 agar lebih praktis dan mudah digunakan. BSTI dapat membantu dokter untuk merekomendasikan produk perawatan kulit harian yang paling sesuai bagi pasien. Hingga saat ini, belum ada klasifikasi penentuan tipe kulit di Indonesia. Oleh karena itu, diperlukan alat yang valid dan reliabel untuk menentukan tipe kulit pada populasi di Indonesia. Penelitian ini bertujuan untuk mengembangkan Baumann Skin Type Indicators berbahasa Indonesia (BSTI-Ina).Metode: Dilakukan penerjemahan dan adaptasi lintas budaya kuesioner BSTI tahun 2006 dan 2022 ke dalam bahasa Indonesia. Hasil terjemahan kuesioner dianalisis oleh komite yang beranggotakan dokter spesialis Dermatologi, Venereologi dan Estetika, ahli biostatistika, psikolog klinis, dan penerjemah. Hasil kuesioner yang telah disepakati oleh komite diisi oleh 150 subjek dewasa yang berusia antara 18 hingga 59 tahun. Validitas kuesioner BSTI-Ina tahun 2006 dan 2022 dinilai berdasarkan validitas konten dan validitas konstruksi. Reliabilitas dinilai berdasarkan konsistensi internal. Korelasi antara kuesioner BSTI-Ina tahun 2006 dan 2022 dinilai dengan intra-class correlation (ICC).Hasil: Uji validitas menghasilkan nilai koefisien korelasi setiap pertanyaan pada BSTI-Ina tahun 2006 sebesar -0,037 hingga 0,751, untuk setiap pertanyaan pada BSTI-Ina tahun 2022 sebesar 0,231 hingga 0,685. Uji reliabilitas menunjukkan nilai α Cronbach untuk setiap pertanyaan pada BSTI-Ina tahun 2006 sebesar 0,613 hingga 0,718 dan untuk seluruh pertanyaan pada BSTI-Ina tahun 2022 sebesar 0,704. Intra-class correlation antara BSTI-Ina tahun 2006 dan 2022 sebesar 0,435.Kesimpulan: Penelitian ini menunjukkan bahwa BSTI-Ina tahun 2006 dan 2022 valid, reliabel, dan dapat digunakan untuk menentukan tipe kulit populasi dewasa di Indonesia.

---

Backgorund: The Baumann Skin Type Indicator (BSTI) is an instrument developed in 2006 to determine skin types based on four dichotomous parameters, which are: dry or oily; sensitive or resistant; pigmented or non-pigmented; and tight or wrinkled. This questionnaire has been modified in 2022 to make it more practical and simple to use. The BSTI can assist dermatologists in recommending the most appropriate daily skin care products for patients. Until now, there is no classification for determining skin type in Indonesia. Therefore, valid and reliable tools are needed for determining skin type in the Indonesian population. This study aims to develop an Indonesian version of Baumann Skin Type Indicators (BSTI-Ina).

Methods: The English versions of 2006 and 2022 BSTI questionnaires were translated into Bahasa Indonesia and underwent cross-cultural adaptation. The translated questionnaires were analyzed by a committee consisting of dermato-venereologists and aestheticians, biostatistician, clinical psychologist, and translators. The questionnaires were completed online by 150 Indonesian adult subjects ranging between 18 and 59 years old. The validity of the translated questionnaires was measured by content and construct validity. The reliability was assessed by internal consistency. The correlation between the 2006 and 2022 BSTI-Ina was assessed by intra-class correlation (ICC).

Results: The validity test showed correlation coefficient scores for each question in 2006 BSTI-Ina was -0,037 to 0.751, and for each question in 2022 BSTI-Ina was 0,231 to 0,685. The reliability test showed a Cronbach’s α coefficient for each question in 2006 BSTI-Ina was 0,613 to 0,718 and for question in 2022 BSTI-Ina was 0,704. The ICC between 2006 and 2022 BSTI- Ina was 0.435.

Conclusion: This study demonstrates that both 2006 and 2022 BSTI-Ina are valid, reliable, and suitable for determining the skin type of the Indonesian adult population."

"Latar belakang: Hampir sebagian besar pasien kanker akan memiliki keluhan kulit, rambut, dan kuku (KRK) terkait efek samping kemoterapi yang diberikan. Antrasiklin merupakan kemoterapi yang banyak digunakan pada pasien kanker. Meskipun jarang mengancam nyawa, kelainan KRK dapat menyebabkan penurunan kualitas hidup. Berbagai faktor risiko berpengaruh terhadap kelainan tersebut. Waktu timbulnya manifestasi kelainan KRK pada pasien kanker yang menjalani kemoterapi berbasis antrasiklin juga beragam munculnya. Penelitian ini bertujuan untuk menganalisis hubungan antara usia, penyakit penyerta sistemik, status gizi, ECOG, dan anemia dengan manifestasi klinis KRK pada pasien kanker yang menjalani dua siklus kemoterapi berbasis antrasiklin.Metode: Penelitian ini merupakan penelitian deskriptif analitik dengan kohort prospektif yang diikuti dalam dua siklus pertama kemoterapi berbasis antrasiklin. Sebesar 65 pasien kanker berusia di atas 18 tahun yang mendapatkan kemoterapi siklus pertama berbasis antrasiklin di RSUPN dr. Cipto Mangunkusumo. Semua SP dilakukan anamnesis, pemeriksaan dermatovenereologikus, dan dokumentasi klinis sampai sebelum kemoterapi siklus ke-3. Pencatatan faktor risiko, jenis, dan waktu timbulnya kelainan dilakukan apabila ditemukan manifestasi KRK.Hasil: Kelainan kulit terbanyak berupa xerosis dan hiperpigmentasi. Anagen effluvium ditemukan pada 89,2% pasien kemoterapi. Melanonikia dan xanthonikia ditemukan pada 87,7% pasien. Xerosis ditemukan dengan median (minimum-maximum) 7 (2-56) hari, anagen effluvium timbul dalam median (minimum-maximum) 13(1-27 hari), dan melanonikia dengan median (minimum-maximum) 23(1-65) hari. Tidak terdapat hubungan antara usia, penyakit penyerta sistemik, status gizi, status performa ECOG, dan anemia dengan manifestasi KRK pada pasien kanker yang menjalani dua siklus kemoterapi berbasis antrasiklin.Kesimpulan: Semua pasien memiliki kelainan KRK. Kelainan yang paling cepat timbul adalah xerosis, diikuti anagen effluvium, dan melanonikia. Tidak ditemukan hubungan antara usia, penyakit penyerta sistemik, status gizi, status performa ECOG, dan anemia dengan manifestasi KRK pada pasien kanker yang menjalani dua siklus kemoterapi berbasis antrasiklin.

---

Background: Nearly most cancer patients experience skin, hair, and nail complaints due to chemotherapy side effects. Anthracycline-based chemotherapy is widely utilized in cancer care. While rarely life-threatening, cutaneous, hair, and nail alterations can significantly impact quality of life. Several risk factors influence these disorders. The onset timing of skin, hair, and nail manifestations varies among cancer patients undergoing anthracycline-based chemotherapy. This study analyses the association between age, systemic comorbidities, nutritional status, ECOG performance status, and anaemia with clinical manifestations of skin, hair, and nails in cancer patients undergoing two cycles of anthracycline-based chemotherapy.

Methods: This is an analytical descriptive study involving a prospective cohort followed during the first two cycles of anthracycline-based chemotherapy. A total of 65 cancer patients aged above 18, receiving the first cycle of anthracycline-based chemotherapy at RSUPN dr. Ciptomangunkusumo, were enrolled. All subjects underwent anamnesis, dermatovenereological examination, and clinical documentation before the third chemotherapy cycle. Risk factors, type, and onset time of abnormalities were recorded upon detection of skin, hair, and nail manifestations.

Results: All patients presented with skin, hair, or nail abnormalities. The most rapidly occurring abnormalities were xerosis, followed by anagen effluvium and melanonychia. No correlation was found between age, systemic comorbidities, nutritional status, ECOG performance status, and anaemia with skin, hair, and nail manifestations in cancer patients undergoing two cycles of anthracycline-based chemotherapy. Conclusions: The most frequent skin abnormalities observed were xerosis and hyperpigmentation. Anagen effluvium was detected in 89.2% of chemotherapy patients. Melanonychia and xanthonychia were found in 87.7% of patients. Xerosis had a median (min-max) onset of 7 (2-56) days, anagen effluvium manifested within a median (min- max) of 13 (1-27) days, and melanonychia with a median (min-max) onset of 23 (1-65) days. There was no association found between age, systemic comorbidities, nutritional status, ECOG performance status, and anaemia with skin, hair, and nail manifestations in cancer patients undergoing two cycles of anthracycline-based chemotherapy."